Chang‐Ching Lin

818 total citations
30 papers, 457 citations indexed

About

Chang‐Ching Lin is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chang‐Ching Lin has authored 30 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chang‐Ching Lin's work include Advanced Breast Cancer Therapies (6 papers), Cancer-related Molecular Pathways (6 papers) and Cancer Cells and Metastasis (4 papers). Chang‐Ching Lin is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), Cancer-related Molecular Pathways (6 papers) and Cancer Cells and Metastasis (4 papers). Chang‐Ching Lin collaborates with scholars based in United States, Taiwan and Italy. Chang‐Ching Lin's co-authors include Duxin Sun, Li‐Heng Pao, Miao‐Chia Lo, Nicholas Stevers, Hui Jiang, Oliver Yoa‐Pu Hu, Ariella B. Hanker, Carlos L. Arteaga, Kyung‐min Lee and Dhivya R. Sudhan and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Cancer Cell.

In The Last Decade

Chang‐Ching Lin

29 papers receiving 448 citations

Peers

Countries citing papers authored by Chang‐Ching Lin

Since Specialization

Citations

This map shows the geographic impact of Chang‐Ching Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Ching Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Ching Lin more than expected).

Fields of papers citing papers by Chang‐Ching Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐Ching Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Ching Lin. The network helps show where Chang‐Ching Lin may publish in the future.

Co-authorship network of co-authors of Chang‐Ching Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Ching Lin. A scholar is included among the top collaborators of Chang‐Ching Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Ching Lin. Chang‐Ching Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor–Positive Breast Cancer 2025 ·Clinical Cancer Research ·Chang‐Ching Lin, (unknown), Nisha Unni, (unknown), Yisheng Fang, Lei Guo, Fabiana Napolitano, (unknown), (unknown), Calvin Chao, Lin Xu, Carlos L. Arteaga, Ariella B. Hanker	2
2	Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer 2024 ·Cancer Letters ·(unknown), Gun Min Kim, (unknown), Fabiana Napolitano, Chang‐Ching Lin, (unknown), (unknown), Yisheng Fang, Kyung‐min Lee, Saurabh Mendiratta, Ariella B. Hanker, Carlos L. Arteaga	3
3	Abstract PO3-23-09: ESR1 mutations drive resistance to CDK4/6 inhibitors in ER+ Breast Cancer 2024 ·Cancer Research ·(unknown), Chang‐Ching Lin, (unknown), (unknown), Lei Guo, (unknown), Fabiana Napolitano, Calvin Chao, Ariella B. Hanker, Carlos L. Arteaga	1
4	Abstract 5483: Combined inhibition of CDK4/6 and AKT is highly active against the luminal androgen receptor (LAR) subtype of triple negative breast cancer (TNBC) 2023 ·Cancer Research ·(unknown), (unknown), Chang‐Ching Lin, Kyung‐min Lee, Fabiana Napolitano, Dan Ye, (unknown), (unknown), Ariella B. Hanker, Carlos L. Arteaga	1
5	Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity 2021 ·Cancer Cell ·Ariella B. Hanker, Benjamin P. Brown, Jens Meiler, Arnaldo Marín, (unknown), Dan Ye, Chang‐Ching Lin, Hiroaki Akamatsu, Kyung‐min Lee, Sumanta Chatterjee, Dhivya R. Sudhan, Alberto Servetto, Monica Red Brewer, James P. Koch, Jonathan H. Sheehan, Jie He, Alshad S. Lalani, Carlos L. Arteaga	53
6	Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER+ Breast Cancer 2021 ·Clinical Cancer Research ·Alberto Servetto, Rahul K. Kollipara, Luigi Formisano, Chang‐Ching Lin, Kyung‐min Lee, Dhivya R. Sudhan, Paula I. González-Ericsson, Sumanta Chatterjee, Ángel Guerrero‐Zotano, Saurabh Mendiratta, Hiroaki Akamatsu, Nicholas G. James, Roberto Bianco, Ariella B. Hanker, Ralf Kittler, Carlos L. Arteaga	44
7	Combined p53- and PTEN-deficiency activates expression of mesenchyme homeobox 1 (MEOX1) required for growth of triple-negative breast cancer 2020 ·Journal of Biological Chemistry ·(unknown), Miao‐Chia Lo, Hui Jiang, Chang‐Ching Lin, Duxin Sun	21
8	Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer 2020 ·Nature Communications ·Kyung‐min Lee, Ángel Guerrero‐Zotano, Alberto Servetto, Dhivya R. Sudhan, Chang‐Ching Lin, Luigi Formisano, Valerie M. Jansen, Paula I. González-Ericsson, Melinda E. Sanders, Thomas Stricker, Ganesh V. Raj, Kevin M. Dean, Reto Fiolka, Lewis C. Cantley, Ariella B. Hanker, Carlos L. Arteaga	34
9	Knowledge in youth is wisdom in age: an empirical study of attorney experience in torts litigation 2020 ·International Review of Law and Economics ·Chang‐Ching Lin, Yun‐chien Chang, Kong-Pin Chen	1
10	Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer 2018 ·Cancer Letters ·Chang‐Ching Lin, Miao‐Chia Lo, (unknown), Hui Jiang, Ramdane Harouaka, Nicholas Stevers, (unknown), (unknown), Max S. Wicha, Duxin Sun	36
11	Doxycycline targets aldehyde dehydrogenase‑positive breast cancer stem cells 2018 ·Oncology Reports ·Chang‐Ching Lin, Miao‐Chia Lo, (unknown), Nicholas Stevers, (unknown), Duxin Sun	21
12	Abstract 2004: Identification of MLK4 as a novel regulator of cancer stem cells in triple-negative breast cancer 2018 ·Cancer Research ·Chang‐Ching Lin, Miao‐Chia Lo, (unknown), Nicholas Stevers, (unknown), (unknown), Max S. Wicha, Duxin Sun	2
13	Probing the interaction between the histone methyltransferase/deacetylase subunit RBBP4/7 and the transcription factor BCL11A in epigenetic complexes 2017 ·Journal of Biological Chemistry ·(unknown), Miao‐Chia Lo, Jennifer L. Meagher, Chang‐Ching Lin, Nicholas Stevers, (unknown), Inkyung Jung, Aleksas Matvekas, Jeanne A. Stuckey, Duxin Sun	44
14	Abstract 4767: Identifying CDCA7 as a novel regulator of tumor-initiating cells in triple-negative breast cancer 2017 ·Cancer Research ·Chang‐Ching Lin, Miao‐Chia Lo, (unknown), Nicholas Stevers, (unknown), Max S. Wicha, Duxin Sun	2
15	Herb-Drug Interaction of 50 Chinese Herbal Medicines on CYP3A4 Activityin Vitroandin Vivo 2012 ·The American Journal of Chinese Medicine ·Li‐Heng Pao, Oliver Yoa‐Pu Hu, (unknown), Chang‐Ching Lin, (unknown), (unknown)	52
16	Development and validation of a liquid chromatography–tandem mass spectrometry method for simultaneous quantification of p-aminohippuric acid and inulin in rat plasma for renal function study 2010 ·Analytical and Bioanalytical Chemistry ·Chang‐Ching Lin, (unknown), Li‐Heng Pao	11
17	Synthesis of N-modified sTn analogs and evaluation of their immunogenicities by microarray-based immunoassay 2010 ·Tetrahedron ·(unknown), Tsung‐Che Chang, Chang‐Ching Lin, (unknown), (unknown), Kuo‐Ting Huang, (unknown), Jia‐Cherng Horng, Ja‐an Annie Ho, Chun‐Cheng Lin	28
18	Determination of p-aminohippuric acid in rat plasma by liquid chromatography-tandem mass spectrometry 2010 ·Journal of Chromatography B ·(unknown), Chang‐Ching Lin, Li‐Heng Pao	4
19	An Empirical Investigation of Settlement and Litigation—The Case of Taiwanese Labor Disputes 2010 ·Journal of Empirical Legal Studies ·Kuo‐Chang Huang, (unknown), Chang‐Ching Lin	14
20	Simultaneous determination of triazolam and its metabolites in human plasma by liquid chromatography–tandem mass spectrometry 2008 ·Journal of Chromatography B ·(unknown), Chang‐Ching Lin, (unknown), (unknown), Li‐Heng Pao	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact